Program areas at Phelan Mcdermid Syndrome Foundation
RESEARCH SUPPORT: The Phelan-McDermid Syndrome Foundation (PMSF) works closely with researchers, pharmacological companies, biotechnology, academic institutions, and other external scientists with the ultimate goal of finding effective treatments for Phelan-McDermid syndrome (PMS). The PMSF contributes to research by breaking down barriers to patient participation. The PMSF provides information about and access to research opportunities as well as offers financial assistance for travel costs to certain research sites. The PMSF also works with its international scientific advisory committee (SAC) to set strategic goals in research and science for the PMSF and to stay informed of international PMS projects and research.
FAMILY SUPPORT: The Phelan-McDermid Syndrome Foundation (PMSF) is the largest patient advocacy group (PAG) for Phelan-McDermid syndrome in the world. The PMSF was established to provide critical information and support to empower families affected by this rare condition. The PMSF and its entire community of families, researchers, clinicians, and friends share everything they know about Phelan-McDermid syndrome and provide connections to a global community. The PMSF has created a worldwide virtual and local community and receives daily contact from families, extended families, clinicians, and researchers through email, social media, phone, and other avenues. Every two years, families, researchers, clinicians, and others who support people with Phelan-McDermid syndrome come together at the International Family Conference to laugh, share and learn. In non-conference years, the PMSF strives to create a virtual or in-person regional conference. The PMSF Regional REPs coordinate periodic in-person gatherings to help families create connections, share stories and support each other.
Grants made by Phelan Mcdermid Syndrome Foundation
Grantee | Grant description | Grant year | Amount |
---|
Boston Children's Hospital | To Understand Whether People With Phelan-Mcdermid Syndrome, Particularly Those With Severe Neuropsychiatric Illness (Snpi) -- Have Underlying Differences in Their Immune System That Might Guide Treatment. | 2023-12 | $100,000 |
Clemson University Foundation | To Study the Response of Cells From Individuals With Phelan-Mcdermid Syndrome To Candidate Therapeutics/treatments (Such As Insulin-Like Growth Factor 1 and Human Growth Hormone) and Identify Subgroups in the Phelan-Mcdermid Syndrome Population That Will Potentially Respond Better Or Worse To the Selected Compounds. | 2023-12 | $55,000 |
University of Miami (UM) | To Develop An Alternative Objective Measure of Gastrointestinal Motility (Gi Transit) in Individuals With Phelan-Mcdermid Syndrome. Muffins With Blue Dye Will Be Ingested By Individuals With Phelan-Mcdermid Syndrome and Caregivers Will Use A Mobile App To Track and Report Gi Transit Time. | 2023-12 | $55,000 |
...and 1 more grant made |
Who funds Phelan Mcdermid Syndrome Foundation
Grants from foundations and other nonprofits
Personnel at Phelan Mcdermid Syndrome Foundation
Name | Title | Compensation | Date of data |
---|
Ronni Blumenthal | Chief Executive Officer | | 2024-09-21 |
Diane Linnehan | Senior Director of Operations | | 2024-09-21 |
Priscilla Hackstadt | Finance Director | $0 | 2024-09-21 |
Shira Johnson | Director of Development | | 2024-09-21 |
Catherine Cat | Valcourt - Pearce Director | | 2022-06-30 |
...and 13 more key personnel |
Financials for Phelan Mcdermid Syndrome Foundation
Revenues | FYE 12/2023 | FYE 12/2022 | % Change |
---|
Total grants, contributions, etc. | $834,914 | $744,192 | 12.2% |
Program services | $110,073 | $34,615 | 218% |
Investment income and dividends | $14,095 | $-8,775 | 260.6% |
Tax-exempt bond proceeds | $0 | $0 | - |
Royalty revenue | $0 | $0 | - |
Net rental income | $0 | $0 | - |
Net gain from sale of non-inventory assets | $0 | $0 | - |
Net income from fundraising events | $103,679 | $83,616 | 24% |
Net income from gaming activities | $0 | $0 | - |
Net income from sales of inventory | $0 | $0 | - |
Miscellaneous revenues | $0 | $0 | - |
Total revenues | $1,062,761 | $853,648 | 24.5% |
Organizations like Phelan Mcdermid Syndrome Foundation
Organization | Type | Location | Revenue |
---|
National Down Syndrome Society (NDSS) | 501(c)(3) | Washington, DC | $3,354,289 |
Spina Bifida Association of America | 501(c)(3) | Arlington, VA | $2,834,510 |
Osteogenesis Imperfecta Foundation | 501(c)(3) | Gaithersburg, MD | $2,214,512 |
Massachusetts Down Syndrome Congress (MDSC) | 501(c)(3) | Burlington, MA | $2,115,140 |
Kentucky Hemophilia Foundation | 501(c)(3) | Louisville, KY | $285,400 |
United Cerebral Palsy | 501(c)(3) | Vienna, VA | $2,223,432 |
Global Down Syndrome Foundation | 501(c)(3) | Denver, CO | $3,826,365 |
Cooley's Anemia Foundation | 501(c)(3) | New York, NY | $2,306,555 |
Virginia Hemophilia Foundation | 501(c)(3) | Richmond, VA | $512,482 |
Adult Congenital Heart Association (ACHA) | 501(c)(3) | Media, PA | $2,407,696 |
Data update history
December 22, 2024
Received grants
Identified 4 new grant, including a grant for $15,000 from Global Genes September 21, 2024
Updated personnel
Identified 6 new personnel
May 28, 2024
Posted financials
Added Form 990 for fiscal year 2023
May 21, 2024
Updated personnel
Identified 1 new personnel
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsCharities
Issues
HealthDiseases and disorders
Characteristics
Political advocacyConducts researchLobbyingFundraising eventsNational levelReceives government fundingEndowed supportTax deductible donationsAccepts online donations
General information
- Address
- 8 Sorrento Dr
- Osprey, FL 34229
- Metro area
- North Port-Sarasota-Bradenton, FL
- County
- Sarasota County, FL
- Website URL
- pmsf.org/Â
- Phone
- (941) 485-8000
IRS details
- EIN
- 04-3673104
- Fiscal year end
- December
- Taxreturn type
- Form 990
- Year formed
- 2002
- Eligible to receive tax-deductible contributions (Pub 78)
- Yes
Categorization
- NTEE code, primary
- G20: Birth Defects and Genetic Diseases
- NAICS code, primary
- 813212: Health and Disease Research Fundraising Organizations
- Parent/child status
- Independent
California AB-488 details
- AB 488 status
- May Operate or Solicit for Charitable Purposes
- Charity Registration status
- Current
- FTB status revoked
- Not revoked
- AG Registration Number
- CT0160270
- FTB Entity ID
- None yet
- AB 488 data last updated ("as-of") date
- 2024-12-18
Free account sign-up
Want updates when Phelan Mcdermid Syndrome Foundation has new information, or want to find more organizations like Phelan Mcdermid Syndrome Foundation?
Create free Cause IQ account